Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
10/2003
10/22/2003EP1353916A2 Pyrazole compounds useful as protein kinase inhibitors
10/22/2003EP1353912A1 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
10/22/2003EP1353909A2 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioidreceptor binding agents
10/22/2003EP1353907A2 Phosphodiesterase 4 inhibitors
10/22/2003EP1353905A2 Piperidine/piperazine-type inhibitors of p38 kinase
10/22/2003EP1353896A2 Synthesis, methods of using, and compositions of hydroxylated cyclobutylalkylamines
10/22/2003EP1353697A1 Method of preparing biological materials and preparation produced using same
10/22/2003EP1353682A1 Method for obtaining an isolated extract of the plant cyclamen europaeum l. and its use as a therapeutic agent
10/22/2003EP1353661A2 Use of an ltb4 antagonist for the treatment and/or prevention of diseases caused by increased expression of mucin genes
10/22/2003EP1353647A2 Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections
10/22/2003EP1056754B1 Phosphate derivatives of diaryl 1,3,4-oxadiazolone
10/22/2003CN1451010A Benzosulfones with calcium antagonist activity
10/22/2003CN1451005A 7-oxo pyridopyrimidines as inhibitors of a cellular proliferation
10/22/2003CN1451004A 7-oxo pyridopyrimidines
10/22/2003CN1450999A Novel piperazine derivatives
10/22/2003CN1450998A Inhibitors of copper-containing amine oxidases
10/22/2003CN1450997A Inhibitors of copper-containing amine oxidases
10/22/2003CN1450891A Formulation based on heparin, glycosaminogl ycan or heparinoid, use of the formulation and the formulation base
10/22/2003CN1450164A Novel coronal virus strain and medicinal use thereof
10/22/2003CN1450066A Porphyrin derivate with macrosubstituent, preparation process thereof and use as small molecule antioxidant
10/22/2003CN1449833A Human SARS immune globulin
10/22/2003CN1449832A Horse SARS-resisting serum
10/22/2003CN1449831A DNA vaccine pVPS2 for SARS virus
10/22/2003CN1449830A DNA vaccine pVFS for SARS virus
10/22/2003CN1449829A DNA vaccine pVPS for SARS virus
10/22/2003CN1449828A DNA vaccine pVPM for SARS virus
10/22/2003CN1449827A DNA vaccine pVPH for SARS virus
10/22/2003CN1449826A Gene vaccine for anti SARS coronal virus and use thereof
10/22/2003CN1449825A Method for inactivating Bordetella bronchiseptica culture, bacteria composition prepared by same and vaccine having same and use thereof
10/22/2003CN1449823A Use of ulinastatin in treating SARS and medicinal composition thereof
10/22/2003CN1449821A Stable recombination human alpha interferon liquid preparation and productive process thereof
10/22/2003CN1449820A Interferon lozenge ice block and making method and use thereof
10/22/2003CN1449818A Decoction for anti-SARS
10/22/2003CN1449817A Traditional Chinese medicine capable of anti-SARS and treating cardio-cerebral vascular embolism
10/22/2003CN1449814A Traditional Chinese medicine composition for treating SARS and preparation process thereof
10/22/2003CN1449811A Qinbei granules preparation for curing cough in children and preparation method thereof
10/22/2003CN1449795A Medicine composition for preventing and treating asthma and chronic bronchitis
10/22/2003CN1449790A Cool and throat-moistening aerosol
10/22/2003CN1449766A Yinhuang (honeysuckle and Rdix astragali) soft capsule pharmaceutics and preparation process thereof
10/22/2003CN1449758A Oral compound slow-released pharmaceutics containing theine and salmol active constituent and preparation process thereof
10/22/2003CN1449755A Dextromethorphan hydrobromide drop pills and preparation process thereof
10/22/2003CN1449753A Chlorogenic acid and isochlorogenic acid composition and medical use thereof
10/22/2003CN1449748A Dry powder microsphere inhalant for lung and preparation process thereof
10/22/2003CN1125082C Human chemokine beta-8 chemokine beta-1 and macrophage inflammatory protein-4
10/22/2003CN1125079C Cyclopeptolides
10/22/2003CN1125070C Pyrrolo [2,3-d] pyrmidine compounds, and compositions and use thereof
10/22/2003CN1125054C Novel imidazolidine derivatives, their preparation their use and pharmaceutical preparations comprising them
10/22/2003CN1125049C New crystal modification N of torasemide
10/22/2003CN1124843C Stable glassy state powder formulations
10/21/2003US6635776 Lipoxin compounds and their use in treating cell proliferative disorders
10/21/2003US6635764 Urea compounds that are muscarinic receptor antagonists and agonists, administering to the mammal the urea compound to treat urinary incontinence, chronic pulmonary obstructive disease, asthma, hyper salivation, blurred vision etc.
10/21/2003US6635762 Monocyclic-7H-pyrrolo[2,3-d]pyrimidine compounds, compositions, and methods of use
10/21/2003US6635680 Controlled release pellet formulation
10/21/2003US6635671 Compounds which affect mRNA stability and uses therefor
10/21/2003US6635669 Kinase inhibitor; benign prostatic hyperplasia
10/21/2003US6635665 Acute respiratory distress syndrome and chronic obstructive pulmonary disease
10/21/2003US6635658 Amino-tetralin derivatives as muscarinic receptor antagonists
10/21/2003US6635644 Pyrimido(1,6-b)pyridazine derivatives used as p38 inhibitors a mammalian protein kinase is involved in cell proliferation, cell death and response to extracellular stimuli
10/21/2003US6635638 Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
10/21/2003US6635637 Cyclic oxyguanidine protease inhibitors
10/21/2003US6635633 Substituted pyrazoles useful for treating autoimmune diseases mediated by cathepsin S
10/21/2003US6635629 For therapy and prophylaxis of inflammation, asthma, an allergic disease, chronic obstructive pulmonary disease, atopic dermatitis, solid tumors, AIDS, ischemia, and cardiac arrhythmias
10/21/2003US6635627 Anti-cancer products for treating cystic fibrosis
10/21/2003US6635451 Conversion of dihomo-gamma linolenic acid (DGLA) to arachidonic acid and in the conversion of 20:4n-3 to eicosapentaenoic acid (EPA); Delta 6 desaturase and Delta 5 desaturase
10/21/2003US6635288 Pulverizing in solvent; therapy for liver disorders
10/21/2003US6635251 Eotaxin-specific antibodies
10/21/2003US6635243 Drug including genetically engineered alpha, beta or gamma interferon, biocompatible polymer selected from group consisting of polyvinylpyrrolidone and polyethylene oxide, and biocompatible antioxidant, and having specified viscosity
10/21/2003CA2310318C Pseudopolymorphic forms of 2-[2-[4-[bis (4-fluorophenyl) methyl]-1-piperazinyl] ethoxy]acetic acid dihydrochloride
10/16/2003WO2003085089A2 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same
10/16/2003WO2003084964A1 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the production thereof
10/16/2003WO2003084961A1 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
10/16/2003WO2003084956A1 Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same
10/16/2003WO2003084955A1 Diazabicyclo alkane derivatives with nk1 antagonistic activity
10/16/2003WO2003084954A1 Tropane derivatives as ccr5 modulators
10/16/2003WO2003084950A1 Synthesis of piperidine and piperazine compounds as ccr5 antagonists
10/16/2003WO2003084943A2 Terphenyl derivatives, preparation thereof, compositions containing same
10/16/2003WO2003084941A2 Hydroxamic acid derivatives
10/16/2003WO2003084940A1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
10/16/2003WO2003084938A2 Pyrimidone derivatives useful for the treatment of inflammatin and immunological diseases
10/16/2003WO2003084937A2 Pyrimidinedione derivatives useful for the treatment of inflammation and immunological diseases
10/16/2003WO2003084936A2 Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological
10/16/2003WO2003084935A2 Diaryl pyrimidinone derivatives useful for the treatment of inflammation and immunogolical diseases
10/16/2003WO2003084560A2 Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis
10/16/2003WO2003084556A1 Process for producing fat composition containing hydrophobic components of glycyrrhiza
10/16/2003WO2003084555A1 Compositions for inhibiting fibrosis
10/16/2003WO2003084549A1 Hormone replacement therapy
10/16/2003WO2003084539A2 New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
10/16/2003WO2003084527A1 Severe sepsis preventive therapeutic agent
10/16/2003WO2003084524A1 Combination therapy for the treatment of conditions with pathogenic inflammatory components
10/16/2003WO2003084521A2 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy
10/16/2003WO2003084519A2 Aerosol formulation for inhalation comprising a tiotropium salt
10/16/2003WO2003084509A1 Powder formulations suitable for inhalation
10/16/2003WO2003084503A2 P38 kinase inhibitors for treating mucus hypersecretion_
10/16/2003WO2003084502A1 Inhalation kit comprisung inhalable powder of tiotropium
10/16/2003WO2003084476A2 Treatment of lung disorder
10/16/2003WO2003068813A3 Group b streptococcus antigen
10/16/2003WO2003051393A3 Enzymatic cleavable reagents for specific delivery to disease sites
10/16/2003WO2003039469A3 Heteroaryl derivatives as superior ligands for nociceptin receptor orl-1
10/16/2003WO2003039439A3 Deuterated pyrazolopyrimidinones and drugs containing said compounds
10/16/2003WO2003039231A3 Compounds and methods for treating transplant rejection
1 ... 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 ... 878